Home/Filings/4/0001209191-23-026093
4//SEC Filing

O'Connor Daniel J. 4

Accession 0001209191-23-026093

CIK 0001836056other

Filed

Apr 27, 8:00 PM ET

Accepted

Apr 28, 5:59 PM ET

Size

5.5 KB

Accession

0001209191-23-026093

Insider Transaction Report

Form 4
Period: 2023-04-26
O'Connor Daniel
DirectorPresident and CEO
Transactions
  • Award

    Ordinary Shares

    2023-04-26+2,750,0002,750,000 total
Footnotes (2)
  • [F1]The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents seven Ordinary Shares of the Issuer.
  • [F2]Represents grant of Restricted Stock Units (the "RSUs") payable solely in Ordinary Shares of the Issuer that vest as follows: (i) 25% of the RSUs will vest on the six-month anniversary of the grant date of April 26, 2023 (the "Grant Date"), (ii) 25% of the RSUs will vest on the 12-month anniversary of the Grant Date, (iii) 25% of the RSUs will vest on the 24-month anniversary of the Grant Date, and (iv) 25% of the RSUs will vest on the 36-month anniversary of the Grant Date.

Issuer

Ambrx Biopharma Inc.

CIK 0001836056

Entity typeother

Related Parties

1
  • filerCIK 0001376847

Filing Metadata

Form type
4
Filed
Apr 27, 8:00 PM ET
Accepted
Apr 28, 5:59 PM ET
Size
5.5 KB